Human influenza A H5N1 in Indonesia: health care service-associated delays in treatment initiation
Authors:
- Wiku AdisasmitoWAWiku Adisasmito
- Dewi Nur AisyahDADewi Nur Aisyah
- Tjandra Yoga AditamaTATjandra Yoga Aditama
- Rita KusriastutiRKRita Kusriastuti
- Agus SuwandonoASAgus Suwandono
- Ondri Dwi SampurnoOSOndri Dwi Sampurno
- Nurshanty A SapadaNSNurshanty A Sapada
- M J N MamahitMMM J N Mamahit
- Anna SwensonASAnna Swenson
- Nancy A DreyerNDNancy A Dreyer
- Richard CokerRCRichard Coker
Open Access
- 11 June 2013
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 13 (1) , 571
Abstract
Indonesia has had more recorded human cases of influenza A H5N1 than any other country, with one of the world’s highest case fatality rates. Understanding barriers to treatment may help ensure life-saving influenza-specific treatment is provided early enough to meaningfully improve clinical outcomes. Data for this observational study of humans infected with influenza A H5N1 were obtained primarily from Ministry of Health, Provincial and District Health Office clinical records. Data included time from symptom onset to presentation for medical care, source of medical care provided, influenza virology, time to initiation of influenza-specific treatment with antiviral drugs, and survival. Data on 124 human cases of virologically confirmed avian influenza were collected between September 2005 and December 2010, representing 73% of all reported Indonesia cases. The median time from health service presentation to antiviral drug initiation was 7.0 days. Time to viral testing was highly correlated with starting antiviral treatment (p < 0.0001). We found substantial variability in the time to viral testing (p = 0.04) by type of medical care provider. Antivirals were started promptly after diagnosis (median 0 days). Delays in the delivery of appropriate care to human cases of avian influenza H5N1 in Indonesia appear related to delays in diagnosis rather than presentation to health care settings. Either cases are not suspected of being H5N1 cases until nearly one week after presenting for medical care, or viral testing and/or antiviral treatment is not available where patients are presenting for care. Health system delays have increased since 2007.Keywords
This publication has 10 references indexed in Scilit:
- Human influenza A H5N1 in Indonesia: health care service-associated delays in treatment initiationBMC Public Health, 2013
- Determinants of Antiviral Effectiveness in Influenza Virus A Subtype H5N1The Journal of Infectious Diseases, 2012
- Effectiveness of Antiviral Treatment in Human Influenza A(H5N1) Infections: Analysis of a Global Patient RegistryThe Journal of Infectious Diseases, 2010
- Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case seriesThe Lancet, 2008
- Update on Avian Influenza A (H5N1) Virus Infection in HumansNew England Journal of Medicine, 2008
- Epidemiology of Cases of H5N1 Virus Infection in Indonesia, July 2005–June 2006The Journal of Infectious Diseases, 2007
- Three Indonesian Clusters of H5N1 Virus Infection in 2005New England Journal of Medicine, 2006
- Avian Influenza A (H5N1) Infection in Eastern Turkey in 2006New England Journal of Medicine, 2006
- Risk of Influenza A (H5N1) Infection among Poultry Workers, Hong Kong, 1997–1998The Journal of Infectious Diseases, 2002
- Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virusThe Lancet, 1998